Masami Nagai
Overview
Explore the profile of Masami Nagai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uehara E, Takeuchi S, Yang Y, Fukumoto T, Matsuhashi Y, Tamura T, et al.
Oncol Lett
. 2012 Jun;
3(1):190-192.
PMID: 22740879
Chronic myelogenous leukemia (CML) has a typical progressive course with transition from a chronic phase to a terminal blast crisis phase. The mechanisms that lead to disease progression remain to...
2.
Suzuki R, Ohtake S, Takeuchi J, Nagai M, Kodera Y, Hamaguchi M, et al.
Int J Hematol
. 2010 Jan;
91(2):303-9.
PMID: 20111912
Immunological phenotyping of acute leukemia have provided enormous and important information for the classification and lineage determination of leukemia. Forty-nine patients with CD7(+) CD56(+) acute myeloid leukemia (AML) were analyzed....
3.
Takita M, Tanaka Y, Matsumura T, Kishi Y, Kodama Y, Nishimura T, et al.
Rural Remote Health
. 2009 Jul;
9(3):1106.
PMID: 19637934
Introduction: The uneven distribution of physicians in Japan disadvantages rural and remote patients with hematological malignancies to the extent that they may not receive standard treatments. There are 7 core...
4.
Tasaka T, Matsuhashi Y, Sadhira K, Matsuoka A, Ohnishi H, Kubota Y, et al.
Leuk Res
. 2008 Aug;
33(1):202-4.
PMID: 18691755
No abstract available.
5.
Matsuhashi Y, Tasaka T, Kakazu N, Nagai M, Sadahira K, Nishida K, et al.
Leuk Lymphoma
. 2007 Apr;
48(4):767-73.
PMID: 17454636
A new cell line, designated UCH1, was established from a patient with splenic marginal zone lymphoma (SMZL). UCH1 cells feature a mature B-cell phenotype, characterized by surface IgM +, kappa+,...
6.
Funamoto Y, Nagai M, Haba R, Ishikawa M, Kishida F, Kohno K, et al.
Diagn Cytopathol
. 2005 Jun;
33(1):20-5.
PMID: 15945083
Our objective was to evaluate the usefulness of cytomorphologic assessment in the accuracy of diagnosis of Hodgkin's disease (HD), using imprint cytological preparations over a 18-yr period. Imprint materials from...
7.
Tamura T, Tasaka T, Fujimoto M, Matsuhashi Y, Fukumot T, Mano S, et al.
Haematologica
. 2004 Sep;
89(9):ECR32.
PMID: 15377484
No abstract available.
8.
Kanda-Akano Y, Nomura K, Fujita Y, Horiike S, Nishida K, Nagai M, et al.
Leuk Lymphoma
. 2004 Sep;
45(8):1559-67.
PMID: 15370207
The present study aimed to characterize the clinical and molecular-cytogenetic features of non-Hodgkin's lymphoma (NHL) with double translocation of the immunoglobulin heavy chain (IGH) gene. G-banding analysis, fluorescence in situ...
9.
Kuwabara H, Yoneda M, Nagai M, Hayasaki H, Mori H
Cancer Lett
. 2004 Jun;
210(1):73-80.
PMID: 15172123
The receptor for hyaluronan mediated motility (RHAMM), a hyaluronan (HA) binding protein, has been shown to play an important role in the motility and invasiveness of malignant cells. We have...
10.
Tasaka T, Matsuhashi Y, Uehara E, Tamura T, Kakazu N, Abe T, et al.
Leuk Lymphoma
. 2004 May;
45(3):621-5.
PMID: 15160929
Acute myeloblastic leukemia cases carrying the translocation t(8;16) (p11;p13) are characterized by the M4 and M5 subtypes, erythrophagocytosis by the blast cells and a poor prognosis, suggesting a new clinical...